<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30062488</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>02</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1432-1335</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>144</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of cancer research and clinical oncology</Title>                <ISOAbbreviation>J. Cancer Res. Clin. Oncol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.</ArticleTitle>            <Pagination>                <MedlinePgn>2059-2066</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00432-018-2714-5</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with non-small cell lung cancer (NSCLC) and a prior or synchronous second malignancy are generally excluded from clinical trials. Therefore, little is known on prevalence and prognosis of these patients.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">1252 patients diagnosed with NSCLC in our center from 2006 to 2017 were studied. Overall survival (OS) of patients with a prior or synchronous malignancy was compared to controls including case-control analysis.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">158 patients (12.6%) had a prior malignancy. The most common sites were prostate (17%), breast (16%), gastrointestinal tract (12%), head and neck (11%), bladder (10%), and lung (8%). Compared to controls, patients with prior malignancy were older (71.3 vs. 67.5 years), but had otherwise better prognostic characteristics (stage I-III 63 vs. 53%). Survival was identical compared to controls [hazard ratio (HR) 1.017, CI 0.776-1.333]. A further 3.5% of patients had a synchronous malignancy including 34% prior lung cancer. Patients with a synchronous malignancy had an earlier stage (I-III 84%), and had longer median OS in unselected patients (38.6 vs. 16.2 months, p = 0.021). However, the case-control analysis showed similar OS [hazard ratio (HR) 0.899, CI 0.497-1.621].</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prior or synchronous second malignancies are common at diagnosis of NSCLC. The sites reflect the high proportion of smokers in the population. The earlier stage of NSCLC with a second malignancy might be attributed to chance finding of NSCLC during follow-up. The second malignancy does not affect OS of NSCLC. Therefore, the exclusion of patients with second malignancies from NSCLC trials should be reconsidered.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Faehling</LastName>                    <ForeName>Martin</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2439-7538</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Cardiology and Pneumology, Hospital Esslingen, Hirschlandstr. 97, 73730, Esslingen, Germany. m.faehling@klinikum-esslingen.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schwenk</LastName>                    <ForeName>Birgit</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiology and Pneumology, Hospital Esslingen, Hirschlandstr. 97, 73730, Esslingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kramberg</LastName>                    <ForeName>Sebastian</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiology and Pneumology, Hospital Esslingen, Hirschlandstr. 97, 73730, Esslingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fallscheer</LastName>                    <ForeName>Sabine</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiology and Pneumology, Hospital Esslingen, Hirschlandstr. 97, 73730, Esslingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Leschke</LastName>                    <ForeName>Matthias</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Cardiology and Pneumology, Hospital Esslingen, Hirschlandstr. 97, 73730, Esslingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sträter</LastName>                    <ForeName>Jörn</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Institute of Pathology Esslingen, Esslingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Eckert</LastName>                    <ForeName>Robert</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Outpatient Cancer Treatment Clinic Esslingen, Esslingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Germany</Country>            <MedlineTA>J Cancer Res Clin Oncol</MedlineTA>            <NlmUniqueID>7902060</NlmUniqueID>            <ISSNLinking>0171-5216</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Lung Cancer. 2001 Apr;32(1):47-53</RefSource>                <PMID Version="1">11282428</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2009 Apr;16(4):1033-8</RefSource>                <PMID Version="1">19190966</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Thorac Cardiovasc Surg. 1975 Oct;70(4):606-12</RefSource>                <PMID Version="1">170482</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Respir Med. 2014 Jun;108(6):910-7</RefSource>                <PMID Version="1">24650574</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Respiration. 2007;74(2):192-5</RefSource>                <PMID Version="1">16699256</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cardiothorac Surg. 2000 Nov;18(5):524-8</RefSource>                <PMID Version="1">11053811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2018 Apr 5;556(7699):12-13</RefSource>                <PMID Version="1">29620747</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Thorac Oncol. 2016 Jan;11(1):39-51</RefSource>                <PMID Version="1">26762738</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2017 Nov 20;35(33):3737-3744</RefSource>                <PMID Version="1">28968170</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cardiothorac Surg. 2007 Oct;32(4):653-8</RefSource>                <PMID Version="1">17707650</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Thorac Surg. 1995 Apr;59(4):863-6; discussion 867</RefSource>                <PMID Version="1">7695410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Lung Cancer. 2017 Sep;18(5):543-550.e3</RefSource>                <PMID Version="1">28412093</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Sep 13;8(44):77897-77914</RefSource>                <PMID Version="1">29100434</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2016 Oct;95(43):e5203</RefSource>                <PMID Version="1">27787376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2014 Sep 24;106(11):null</RefSource>                <PMID Version="1">25253615</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chest. 2005 Apr;127(4):1152-8</RefSource>                <PMID Version="1">15821189</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018287" MajorTopicYN="N">Carcinoma, Large Cell</DescriptorName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016609" MajorTopicYN="N">Neoplasms, Second Primary</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Lung cancer</Keyword>            <Keyword MajorTopicYN="N">Prevalence</Keyword>            <Keyword MajorTopicYN="N">Previous malignancy</Keyword>            <Keyword MajorTopicYN="N">Prognosis</Keyword>            <Keyword MajorTopicYN="N">Real-life data</Keyword>            <Keyword MajorTopicYN="N">Survival</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30062488</ArticleId>            <ArticleId IdType="doi">10.1007/s00432-018-2714-5</ArticleId>            <ArticleId IdType="pii">10.1007/s00432-018-2714-5</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>